Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Head and Neck Neoplasms 3 Polycystic Ovary Syndrome 2 Pain 2 Neoplasms 2 Endocrine System Diseases 2 Amenorrhea 2 Trismus 1 Thrombosis 1 Neuroma 1 Movement Disorders 1 Motor Activity 1 Lymphedema 1 Health Education 1 Fibrosis 1 Deglutition Disorders 1 Anxiety Disorders 1 Agnosia 1

Interventions

Magnetic Resonance Spectroscopy 5 Pentoxifylline 4 Liver Transplantation 4 Blood Specimen Collection 4 Specimen Handling 3 High-Energy Shock Waves 3 Tocopherols 2 Sorafenib 2 Simvastatin 2 Low-Level Light Therapy 2 Gemcitabine 2 tremelimumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 navitoclax 1 maltodextrin 1 esmolol 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 atezolizumab 1 apixaban 1 alpha-Tocopherol 1 Viusid 1 Vitamin E 1 Vitamin D 1 Tenofovir 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fibrosis × Musculoskeletal Manipulations × Clear all

NCT03612531 2026-04-23

MANTLE

M.D. Anderson Cancer Center

Phase NA Active not recruiting

Deglutition Disorders, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡